Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071-Reference-Cited by-同舟云学术

Cholesterol biosynthesis inhibitors as potent novel anti-cancer agents: suppression of hormone-dependent breast cancer by the oxidosqualene cyclase inhibitor RO 48-8071

Published:2014-05-31 Issue:1 Volume:146 Page:51-62
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Liang Yayun,Besch-Williford Cynthia,Aebi Johannes D.,Mafuvadze Benford,Cook Matthew T.,Zou Xiaoqin,Hyder Salman M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-2996-5.pdf

Reference50 articles.

1. D’Abreo N, Hindenburg AA (2013) Sex hormone receptors in breast cancer. Vitam Horm 93:99–1331

2. Cordera F, Jordan VC (2006) Steroid receptors and their role in the biology and control of breast cancer growth. Semin Oncol 33:631–641

3. White R, Parker MG (1998) Molecular mechanisms of steroid hormone action. Endocr Relat Cancer 5:1–14

4. Pasqualini JR, Katzenellenbogen BS (eds) (1996) Hormone-dependent cancer. Marcel Dekker Inc., New York

5. Seeger H, Wallwiener D, Mueck AO (2008) Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis. Gynecol Endocrinol 24:576–579

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer;Nature Communications;2024-07-12

2. Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer;Biomolecules;2024-01-03

3. Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway;Oncology Letters;2023-05-23

4. The role of cholesterol metabolism in tumor therapy, from bench to bed;Frontiers in Pharmacology;2023-04-06

5. De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue;Exploration of Targeted Anti-tumor Therapy;2022-12-28